These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 22932024)

  • 1. Operational research and HIV policy and guidelines: lessons from a study of patients lost to follow-up from a public antiretroviral treatment program in Cameroon.
    Mben JM; Kouanfack C; Essomba CN; Mbougua JB; Kenfack A; Tonfack CA; Laborde-Balen G; Bourgeois A; Biwolé-Sida M; Delaporte E; Laurent C
    J Public Health Policy; 2012 Nov; 33(4):462-77. PubMed ID: 22932024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementing operational research to scale-up access to antiretroviral therapy for HIV infection: lessons learned from the Cameroonian experience.
    Boyer S; Koulla-Shiro S; Abé C; Spire B; Moatti JP
    Curr Opin HIV AIDS; 2011 Jul; 6(4):239-44. PubMed ID: 21537170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involving new actors to achieve ART scaling-up: difficulties in an HIV/AIDS counselling and testing centre in Cameroon.
    Yakam JC; Gruénais ME
    Int Nurs Rev; 2009 Mar; 56(1):50-7. PubMed ID: 19239516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral therapy in public and private routine health care clinics in Cameroon: lessons from the Douala antiretroviral (DARVIR) initiative.
    Laurent C; Meilo H; Guiard-Schmid JB; Mapouré Y; Noël JM; M'Bangué M; Joko A; Rozenbaum W; Ntoné FN; Delaporte E
    Clin Infect Dis; 2005 Jul; 41(1):108-11. PubMed ID: 15937770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decentralization of access to antiretroviral therapy in Cameroon: correlates of HIV physicians' knowledge in HIV care.
    Rasson S; Boyer S; Fugon L; Protopopescu C; Marcellin F; Koulla-Shiro S; Kouanfack C; Spire B; Moatti JP; Carrieri MP;
    Antivir Ther; 2011; 16(3):423-8. PubMed ID: 21555826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thirty years of tuberculosis control in Cameroon: alternating "vertical" and "horizontal" health care delivery systems].
    Keugoung B; Buve A; Nolna D; Macq J; Meli J; Criel B
    Rev Epidemiol Sante Publique; 2013 Apr; 61(2):129-38. PubMed ID: 23499297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated HIV prevention and care strengthens primary health care: lessons from rural Haiti.
    Walton DA; Farmer PE; Lambert W; Léandre F; Koenig SP; Mukherjee JS
    J Public Health Policy; 2004; 25(2):137-58. PubMed ID: 15255381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The public health approach to antiretroviral treatment (ART) service scale-up in Ethiopia: the first two years of free ART, 2005-2007.
    Assefa Y; Kloos H
    Ethiop Med J; 2008 Oct; 46(4):401-6. PubMed ID: 19271406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scale-up of HIV care and treatment: can it transform healthcare services in resource-limited settings?
    El-Sadr WM; Abrams EJ
    AIDS; 2007 Oct; 21 Suppl 5():S65-70. PubMed ID: 18090271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs.
    Verguet S; Lim SS; Murray CJ; Gakidou E; Salomon JA
    J Infect Dis; 2013 Jan; 207(1):72-9. PubMed ID: 23100567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients.
    Aghokeng AF; Kouanfack C; Laurent C; Ebong E; Atem-Tambe A; Butel C; Montavon C; Mpoudi-Ngole E; Delaporte E; Peeters M
    AIDS; 2011 Nov; 25(17):2183-8. PubMed ID: 21860346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with late antiretroviral therapy initiation in Cameroon: a representative multilevel analysis.
    Ndawinz JD; Chaix B; Koulla-Shiro S; Delaporte E; Okouda B; Abanda A; Tchomthe S; Mboui E; Costagliola D; Supervie V
    J Antimicrob Chemother; 2013 Jun; 68(6):1388-99. PubMed ID: 23391713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low levels of antiretroviral-resistant HIV infection in a routine clinic in Cameroon that uses the World Health Organization (WHO) public health approach to monitor antiretroviral treatment and adequacy with the WHO recommendation for second-line treatment.
    Kouanfack C; Montavon C; Laurent C; Aghokeng A; Kenfack A; Bourgeois A; Koulla-Shiro S; Mpoudi-Ngole E; Peeters M; Delaporte E
    Clin Infect Dis; 2009 May; 48(9):1318-22. PubMed ID: 19320592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early initiation of antiretroviral therapy and universal HIV testing in sub-Saharan Africa: has WHO offered a milestone for HIV prevention?
    Menon S
    J Public Health Policy; 2010 Dec; 31(4):385-400. PubMed ID: 21119646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Implementation of a continuum of care for people living with HIV/AIDS in Hanoi (Vietnam)].
    de Loenzien M
    Sante; 2009; 19(3):141-8. PubMed ID: 20185390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of unplanned antiretroviral treatment interruptions among people living with HIV in Yaoundé, Cameroon (EVAL survey, ANRS 12-116).
    Marcellin F; Boyer S; Protopopescu C; Dia A; Ongolo-Zogo P; Koulla-Shiro S; Abega SC; Abé C; Moatti JP; Spire B; Carrieri MP;
    Trop Med Int Health; 2008 Dec; 13(12):1470-8. PubMed ID: 19000156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of HIV care decentralization from the patient's perspective: health-related quality of life and perceived quality of services in Cameroon.
    Boyer S; Protopopescu C; Marcellin F; Carrieri MP; Koulla-Shiro S; Moatti JP; Spire B;
    Health Policy Plan; 2012 Jul; 27(4):301-15. PubMed ID: 21690123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adult population impact of HIV care and antiretroviral therapy in a resource poor setting, 2003-2008.
    Gargano JW; Laserson K; Muttai H; Odhiambo F; Orimba V; Adamu-Zeh M; Williamson J; Sewe M; Nyabiage L; Owuor K; Broz D; Marston B; Ackers M
    AIDS; 2012 Jul; 26(12):1545-54. PubMed ID: 22441254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance.
    Bennett DE; Bertagnolio S; Sutherland D; Gilks CF
    Antivir Ther; 2008; 13 Suppl 2():1-13. PubMed ID: 18578063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of wasting and opportunistic infections in HIV-infected patients in West Africa: a realistic and necessary strategy before antiretroviral treatment].
    Ledru é ; Sanou PT; Dembele M; Dahourou H; Zoubga A; Durand G
    Sante; 1999; 9(5):293-300. PubMed ID: 10657773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.